Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05512013 · ClinicalTrials.gov registry record · Phase 1
The Effects of NSAIDs on Bone Metabolism Following Exercise
A Phase 1 study, sponsored by United States Army Research Institute of Environmental Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT05512013: Completed Phase 1 study, sponsored by United States Army Research Institute of Environmental Medicine.
NCT05512013 is a Phase 1 study that has completed, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 12 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05512013, a Phase 1 study, has completed, sponsored by United States Army Research Institute of Environmental Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of a single dose of non-steroidal anti-inflammatory drugs on post-exercise markers of bone and muscle metabolism.
Primary Outcome
Concentration (pg/mL) of serum N-terminal propeptide of type 1 collagen (P1NP)
Interventions
- DRUG Placebo
- DRUG Ibuprofen 800 mg
- DRUG Celecoxib 200mg
- DRUG Flurbiprofen 100 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-02-15 |
| Est. Completion | 2023-04-01 |
| Phase | Phase 1 |
What the finished NCT05512013 record still lists
NCT05512013 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT05512013 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05512013 about?
NCT05512013 is a clinical study titled "The Effects of NSAIDs on Bone Metabolism Following Exercise". The purpose of this study is to determine the effects of a single dose of non-steroidal anti-inflammatory drugs on post-exercise markers of bone and muscle metabolism.
What is the current status of trial NCT05512013?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2022-02-15. Estimated completion is 2023-04-01.
What interventions are being tested in trial NCT05512013?
The interventions under investigation include: Placebo (DRUG), Ibuprofen 800 mg (DRUG), Celecoxib 200mg (DRUG), Flurbiprofen 100 mg (DRUG).
Who is sponsoring clinical trial NCT05512013?
This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05512013's enrollment target sits among peer trials
12 1852nd of 2000 higher than 90 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI